John L. Berk

Boston University — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

53h-index18.0kcitations279works11.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Amyloidosis: Diagnosis, Treatment, Outcomes(231), Parathyroid Disorders and Treatments(60), Peptidase Inhibition and Analysis(27), Protein Kinase Regulation and GTPase Signaling(26), Eosinophilic Disorders and Syndromes(26)

Publications277 total

Efficacy of Acoramidis in Wild-Type and Variant Transthyretin Amyloid Cardiomyopathy
JAMA Cardiology·2025Open Access
Abstract 4368295: Acoramidis Reduces All-Cause Mortality and First Cardiovascular Hospitalization in Patients with Variant Transthyretin Amyloid Cardiomyopathy: Results From the ATTRibute-CM Study
Circulation·2025
Neuropathy impairment and nutritional status with eplontersen in patients with hereditary transthyretin-mediated amyloidosis
Amyloid·2025Open Access
Acoramidis Improves Serum Transthyretin Levels in Patients With Wild-type or Variant Transthyretin Amyloid Cardiomyopathy - Results From ATTRibute-CM
Journal of Nuclear Cardiology·2025
Impact of Vutrisiran on Cardiac Biomarkers in Patients With Transthyretin Amyloidosis With Cardiomyopathy From HELIOS-B
Journal of the American College of Cardiology·2025· 4 citedOpen Access
RWD106 Cardiovascular Morbidity and Mortality Among ATTR-CM Patients Treated with Tafamidis in the US
Value in Health·2025
Benefits of Patisiran on Functional Capacity in ATTR Cardiac Amyloidosis
JACC Advances·2025Open Access
Changing Treatment Landscape in Transthyretin Cardiac Amyloidosis
Circulation Heart Failure·2025· 8 citedOpen Access
Correction: Switching from inotersen to eplontersen in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: analysis from NEURO-TTRansform
Journal of Neurology·2025Open Access
Five-Year Results With Patisiran for Hereditary Transthyretin Amyloidosis With Polyneuropathy
JAMA Neurology·2025· 20 citedOpen Access
Kidney Function And Proteinuria With Eplontersen Treatment For Hereditary Transthyretin Amyloidosis
Journal of Cardiac Failure·2025
Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial
Figshare·2025Open Access
Principaux résultats d’HELIOS-B, étude de phase 3 évaluant le vutrisiran chez les patients atteints d’amylose à transthyrétine avec cardiomyopathie
La Revue de Médecine Interne·2024
Estimating Meaningful Differences in Measures of Neuropathic Impairment, Health‐Related Quality of Life, and Nutritional Status in Patients With Hereditary Transthyretin Amyloidosis
Muscle & Nerve·2024· 2 citedOpen Access
Effects of eplontersen on symptoms of autonomic neuropathy in hereditary transthyretin-mediated amyloidosis: secondary analysis from the NEURO-TTRansform trial
Amyloid·2024· 4 citedOpen Access
Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy
New England Journal of Medicine·2024· 286 citedOpen Access
Switching from inotersen to eplontersen in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: analysis from NEURO-TTRansform
Journal of Neurology·2024· 8 citedOpen Access
Advancing Transthyretin Amyloidosis Drug Development in an Evolving Treatment Landscape: Amyloidosis Forum Meeting Proceedings
Advances in Therapy·2024· 5 citedOpen Access
Eplontersen for Hereditary Transthyretin Amyloidosis With Polyneuropathy: An Exploratory Analysis of Treatment Effect in Male and Female Patients PC112 (#202)
2024
Neuropathy Impairment and Nutritional Status with Eplontersen in Patients with Hereditary Transthyretin-Mediated Amyloidosis PC106 (#174)
2024
page 1 of 14Next →

Frequent Co-authors

Vaishali Sanchorawala(15), Teresa Coelho(14), David C. Seldin(14), Frederick L. Ruberg(12), Martha Skinner(12), David Adams(10), Rodney H. Falk(10), Laura M. Dember(10), P. James B. Dyck(9), Julian D. Gillmore(9), Márcia Waddington‐Cruz(9), Laura Obici(9), Violaine Planté‐Bordeneuve(8), Isabel Conceição(8), Alejandra González‐Duarte(7), Hartmut Schmidt(7), Thomas H. Brannagan(7), Michael Polydefkis(7), Giampaolo Merlini(7), Daniel G. Wright(7)